Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

The research at Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau includes clinical studies in neoplasms, especially colon cancer and relapsed or refractory multiple myeloma. These trials are focused on testing new treatment approaches and tailoring care to the biological features of each patient.

• Personalized treatment strategies for colon cancer after surgery
• New combination therapies for multiple myeloma

This work reflects a strong interest in improving outcomes through more precise and effective cancer care.

Trials in cardiovascular diseases and nervous system diseases examine conditions such as intracerebral hemorrhage, acute ischemic stroke, and atrial fibrillation. The main goal is to evaluate better ways to prevent complications and reduce the risk of future events after a stroke-related illness.

• Strategies to lower recurrence risk after spontaneous lobar ICH
• Early rhythm control for atrial fibrillation after stroke

These studies support safer long-term management of patients with complex brain and heart conditions.

The site also conducts research in insomnia disorder, with a focus on children and adolescents. These studies aim to better understand sleep treatment options and determine which therapies may improve sleep quality in younger patients.

• Evaluation of treatments for pediatric insomnia
• Testing the effectiveness of sleep-related therapies

This area highlights an effort to expand evidence-based care for sleep disorders in younger populations.

Research in immune system diseases includes studies on allergy that assess how quickly treatments relieve histamine-related skin reactions. The purpose is to compare commonly used options and improve understanding of their short-term effects.

• Comparing oral treatments for allergic symptoms
• Measuring the onset of action in histamine-induced skin reactions

This line of research helps clarify how well allergy medicines work in everyday symptom control.

The clinical trial portfolio also covers female urogenital diseases and related symptom research, including primary dysmenorrhea. These studies are designed to assess new treatment options for menstrual pain and improve quality of life for women affected by this condition.

• New approaches for primary dysmenorrhea
• Evaluating symptom relief in women’s health

This research supports better treatment choices for common but often disruptive gynecologic symptoms.

Some studies at this Barcelona site focus on analytical, diagnostic and therapeutic techniques and equipment, including research in healthy volunteers. These trials are intended to assess safety, tolerability, and biological activity while supporting the development of new medical options.

• Safety and tolerability studies in healthy volunteers
• Early evaluation of new treatment candidates

This work contributes to the broader development of future diagnostic and therapeutic tools.